Acurx Pharmaceuticals, Inc. short interest in 2026
In 2026, Acurx Pharmaceuticals, Inc.'s disclosed short interest ran from 3.82% of shares outstanding on 15 Jan 2026 to 2.35% on 15 Sep 2026, a change of -1.47 percentage points. The year's high was 36.63% on 13 Mar 2026 and its low 1.79% on 14 Aug 2026, averaging 7.07% across 8 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 2.09 days on 13 Feb 2026. Full history: Acurx Pharmaceuticals, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 3.82% (15 Jan 2026)
- End of year
- 2.35% (15 Sep 2026)
- Change
- -1.47 pp
- High
- 36.63% (13 Mar 2026)
- Low
- 1.79% (14 Aug 2026)
- Average
- 7.07%
- Highest days to cover
- 2.09 (13 Feb 2026)
- SEC filings marked
- 3
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 3.82% | 1.37 | |
| 30 Jan 2026 | 3.40% | 1.67 | |
| 13 Feb 2026 | 3.54% | 2.09 | |
| 27 Feb 2026 | 2.77% | 1.00 | |
| 13 Mar 2026 | 36.63% | 1.00 | 10-K filed |
| 14 Aug 2026 | 1.79% | 1.00 | 10-Q filed, 10-Q filed |
| 31 Aug 2026 | 2.29% | 1.00 | |
| 15 Sep 2026 | 2.35% | 1.84 |
See also: Acurx Pharmaceuticals, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.